News und Analysen
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors
Partners Group closes its fifth direct private equity program with total commitments above its target of USD 15 billion
Partners Group closes its fifth direct private equity program with total commitments above its target of USD 15 billion
Private Equity Holding AG: Shareholders of Private Equity Holding AG approve all proposals by the Board of Directors
Private Equity Holding AG: Shareholders of Private Equity Holding AG approve all proposals by the Board of Directors
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
Partners Group announces results of the 2024 Annual General Meeting of Shareholders
Partners Group announces results of the 2024 Annual General Meeting of Shareholders
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
HBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin America
HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
HBM Healthcare Investments achieves a balanced result in the 2023/2024 financial year
Private Equity Holding AG: Annual Results / Annual General Meeting on June 3, 2024 in Zug
Private Equity Holding AG: Annual Results / Annual General Meeting on June 3, 2024 in Zug
Private Equity Holding AG: Proposals to the Annual General Meeting of Private Equity Holding AG
Private Equity Holding AG: Proposals to the Annual General Meeting of Private Equity Holding AG
Cembra shareholders approve all proposals of the Board of Directors
Cembra shareholders approve all proposals of the Board of Directors
Private Equity Holding AG: Net Asset Value as of March 31, 2024
Private Equity Holding AG: Net Asset Value as of March 31, 2024
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million
HBM Healthcare Investments publishes net asset value per share (NAV) of CHF 248.10 as at 31 March 2024 and quarterly profit of CHF 156 million
Cembra publishes invitation to the Annual General Meeting 2024 and its Annual Report 2023
Cembra publishes invitation to the Annual General Meeting 2024 and its Annual Report 2023
Annual General Meeting of Bellevue Group AG – all proposals approved
Annual General Meeting of Bellevue Group AG – all proposals approved
Partners Group's USD AuM growth of 8% translated into stable profit of CHF 1 billion, impacted by foreign exchange effects; performance fees up 37%
Partners Group's USD AuM growth of 8% translated into stable profit of CHF 1 billion, impacted by foreign exchange effects; performance fees up 37%
Partners Group adds private markets royalties to its investment platform
Partners Group adds private markets royalties to its investment platform
Changes in the Management Board and the Board of Directors of Cembra
Changes in the Management Board and the Board of Directors of Cembra